President Biden visits the Viral Pathogenesis Laboratory President Joe Biden on Thursday is expected to announce that the White House has secured an additional 200 million doses of COVID-19 vaccine,...

CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the company’s lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. Cyto-111...

SARASOTA, Fla. and NOVATO, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) — GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), companies partnered in the development of intrathecally...